Close
Alm. Brand A/S – Weekly report on share buybacks Jun 10, 2024 03:31AM

Alm. Brand A/S share buy-back program

Transactions during 03 June 2024 – 07 June 2024On 5 December 2023, Alm. Brand A/S announced a share buy-back program of up to DKK 250 million, as described in company announcement no. 23/2023. On 8 February 2024, Alm. Brand A/S announced an increase of the existing share buy-back programme by DKK 100 million to DKK 350 million and extension of the period for the programme until and including 30 September 2024, as described in... (continue reading...)


Global Startup Ecosystem Report 2024 Showcases Surging Investment in Generative AI Jun 10, 2024 03:30AM

Global rankings and trends from the world's most comprehensive, quality-controlled dataset

SAN FRANCISCO, CA / ACCESSWIRE / June 10, 2024 / The 2024 Global Startup Ecosystem Report (GSER) by Startup Genome and the Global Entrepreneurship Network launched today at London Tech Week, in collaboration with the Founders Forum, Informa Tech and London & Partners. The GSER analyzes data from over 4.5 million companies across 300+ entrepreneurial innovation ecosystems and... (continue reading...)


XRP Healthcare Welcomes 10 Billion Dollar M&A Specialist Whitney Lynn to Head Africa Expansion Jun 10, 2024 03:30AM

DUBAI, UAE, June 10, 2024 /PRNewswire/ -- XRP Healthcare, a trailblazer in the healthcare sector, is proud to announce the appointment of Mergers and Acquisitions specialist Whitney Lynn as its new Chairman.

This strategic move comes as XRP Healthcare is set to embark on an ambitious mergers and acquisitions (M&A) venture, having successfully registered... (continue reading...)


Ariceum Therapeutics to Present Outstanding New Preclinical Data at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting 2024 Jun 10, 2024 03:30AM
  • SST2 antagonist, 225Ac-SSO110 (satoreotide), is multiple times more potent than SST2 agonist, 225Ac-DOTATATE
  • Satoreotide demonstrated durable complete response in standard murine xenograft models of Small Cell Lung Cancer in animal models, versus tumor growth delay with 225Ac-DOTATATE

BERLIN, June 10, 2024 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain... (continue reading...)


Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics Jun 10, 2024 03:30AM
  • Commit Biologics is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmune diseases
  • Poster to be presented on Commit's Bispecific Complement Engaging (BiCE™) platform

AARHUS, Denmark, June 10, 2024 /PRNewswire/ -- Commit Biologics ("Commit"), a pioneer in the activation of the complement system to treat cancer and autoimmune disease, today announces it will present a poster containing key data on its... (continue reading...)


More Press Releases

View Older Stories

Jun 10, 2024 03:30AM 50-State Data: Pandemic Learning Loss, Failure to Equip Children for School Threatens U.S. Economy, Young People’s Future
Jun 10, 2024 03:24AM India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad
Jun 10, 2024 03:20AM Slate Asset Management Acquires the World Seafood Center in Oslo for Approximately NOK 1.3 Billion
Jun 10, 2024 03:15AM Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024
Jun 10, 2024 01:41AM Indonesia's Intellectual Property Office Wins Award in Fight Against Piracy at Interpol Conference
Jun 10, 2024 03:04AM Flash News: OKX Wallet Now Supports Full Force
Jun 10, 2024 03:00AM RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon
Jun 10, 2024 03:00AM Flamingo Therapeutics Announces Poster Presentation at EACR 2024 Congress on FLM-7523 (FTX-001), a First-in-Class Inhibitor of the Long Non-Coding RNA MALAT1
Jun 10, 2024 03:00AM Dstny honored with 'Employee Wellbeing Award'
Jun 10, 2024 03:00AM Entrust Enables Governments to Transform Citizen Interactions with Digital Identities
Jun 10, 2024 03:00AM Best’s Market Segment Report: AM Best Revises Outlook for Global Reinsurance Industry to Positive
Jun 10, 2024 03:00AM MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence
Jun 10, 2024 03:00AM Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
Jun 10, 2024 02:57AM Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
Jun 10, 2024 02:55AM Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
Jun 10, 2024 02:51AM Share buy-back programme - week 23
Jun 10, 2024 02:51AM Anmodning om suspension i enkelte afdelinger under Investeringsforeningen Danske Invest
Jun 10, 2024 02:45AM Enduring role of 'treasuring the past' hailed
Jun 10, 2024 02:45AM Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
Jun 10, 2024 02:45AM Virginie Leroy joins VINCI’s Executive Committee
Jun 10, 2024 02:40AM Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity
Jun 10, 2024 02:33AM Preliminary data on early redemptions (prepayments)
Jun 10, 2024 02:33AM The sales of VILVI GROUP May 2024
Jun 10, 2024 02:22AM Share repurchase programme
Jun 10, 2024 02:18AM Quantexa Debuts Q Assist, New Context Aware Generative AI Technology Suite
Jun 10, 2024 02:00AM InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 10
Jun 10, 2024 02:18AM
Jun 10, 2024 02:15AM The ECB has issued permission for Laura Križinauskienė to start taking the position of a member of the Management Board of Šiaulių Bankas
Jun 10, 2024 12:46AM PowerUP Asia 2024 Opens Tomorrow
Jun 10, 2024 02:10AM Exor Press Release - Periodic Report on the Buyback Program
Jun 10, 2024 02:05AM FDA Approves Almirall’s Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis on Expanded Area of Face or Scalp up to 100 cm²
Jun 10, 2024 02:05AM Blueshift Named Market Leader in Research In Action's 2024 Vendor Selection Matrix™ Report for Customer Data Management
Jun 10, 2024 02:00AM Mkango Resources Limited Announces Hypromag to Collaborate with Envipro
Jun 10, 2024 02:00AM Noble Corporation plc announces agreement to acquire Diamond Offshore Drilling, Inc.
Jun 10, 2024 02:00AM Milliman Opens Modelling Excellence Center in Madrid
Jun 10, 2024 02:00AM Medincell Publishes Its Consolidated Annual Financial Results
Jun 10, 2024 02:00AM Regenx Rights Offering Fully Subscribed
Jun 10, 2024 02:00AM Rockit™ Apple fired up to Ready. Set. Rockit. into record season
Jun 10, 2024 02:00AM Distributor Orders Nexstim NBS System 5 for European Hospital
Jun 10, 2024 02:00AM Subsea7 share repurchases
Jun 10, 2024 02:00AM Shell plc First Quarter 2024 Euro and GBP Equivalent Dividend Payments
Jun 10, 2024 02:00AM
Jun 10, 2024 02:00AM Transaction in Own Shares
Jun 10, 2024 02:00AM Fingerprint Cards AB (publ) will present at Aktiedagarna in Stockholm on June 12, 2024
Jun 10, 2024 01:56AM J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study
Jun 10, 2024 02:48AM Mini Harambe uses a Revolutionary Force for Wildlife and Rainforest Conservation
Jun 10, 2024 01:44AM Neorejuvenation Explores University Collaborations to Study Belief Change and Neuroplasticity
Jun 10, 2024 01:30AM 4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients
Jun 10, 2024 01:30AM BGHL (GBP): NAV(s)
Jun 10, 2024 01:30AM BGHL (EUR): NAV(s)
View Older Stories